Gastrointestinal Market Research Reports & Industry Analysis
While many of these illnesses are chronic and can only be treated medically, more holistic and natural approaches are being used more frequently to prevent and manage gastrointestinal disorders. Many healthcare providers are recommending stress management, a healthy diet, and exercise to prevent and manage symptoms.
Exercise has shown to decrease the risk of colon cancer, minimize constipation and improve overall GI health. Even minimal exercise paired with a healthy diet of fruits, vegetables, low fat protein and avoidance of red meat, animal fat, and processed meats, can go a long way in preventing colon cancer and other GI diseases.
It is known that psychological stress can aggravate symptoms of Crohn’s disease, irritable bowel syndrome, and ulcerative colitis. Taking a mind-body approach to health can help these patients manage their illnesses. Techniques such as yoga, meditation, massage, and acupuncture can lower stress and in turn reduce bowel symptoms. Doctors also recommend an anti-inflammatory diet (omega-3 fatty acids, fruits & vegetables, and protein rich food like fish, chicken and soy) for people suffering from Crohn’s disease.
Filter your search
Research Assistance
Gastrointestinal Industry Research & Market Reports
-
Asia Pacific Chronic Idiopathic Constipation (Cic) Drug Market Forecast 2018-2026
... The region is considered to be the most promising and lucrative market for CIC drugs and is expected to grow at a considerable pace over the projected years. MARKET INSIGHTS The Asian CIC drug market ... Read More
-
North America Chronic Idiopathic Constipation (Cic) Drug Market Forecast 2018-2026
... market value is expected to rise from $xx million in 2017 and reach $xx million by 2026. The changing modern dietary habits, chances of cancer or other systematic disease leading to CIC and the growing ... Read More
-
Global Chronic Idiopathic Constipation (Cic) Drug Market Forecast 2018-2026
... drivers propelling the market growth are the modern dietary habits, rising elderly population and the improved and efficient drugs in the pipeline. Linaclotide is a major type of drug that is popular in this market. ... Read More
-
Europe Chronic Idiopathic Constipation (Cic) Drug Market Forecast 2018-2026
... this region and has been altered in the last few years due to the changing needs of society and awareness towards leading a healthy life. The Europe chronic idiopathic constipation drug market is estimated to ... Read More
-
Gastritis - Pipeline Review, H1 2018
... characterized by inflammation or swelling of the lining of the stomach. Acute gastritis lasts for a short period of time while chronic gastritis lasts for a long period of time (months to years). Gastritis can ... Read More
-
Irritable Bowel Syndrome - Pipeline Review, H1 2018
... Syndrome (Gastrointestinal) pipeline landscape. Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder that affects large intestine (colon). Symptoms include cramping, abdominal pain, bloating gas, diarrhea, backache, muscle pains, poor appetite and constipation. These symptoms ... Read More
-
Global and Chinese Gastrointestinal Biopsy Forceps Industry, 2018 Market Research Report
... the Chinese market. The report provides key statistics on the market status of the Gastrointestinal Biopsy Forceps manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Firstly, ... Read More
-
Global and Chinese Gastric Lavage Sets Industry, 2018 Market Research Report
... the Chinese market. The report provides key statistics on the market status of the Gastric Lavage Sets manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Firstly, ... Read More
-
Oncology Nutrition Market by Cancer Type (Head & Neck, Stomach & Gastrointestinal, Liver, Pancreatic, Esophageal, Lung, Breast, Blood) - Global Forecast to 2023
... of 8.7% between 2018 and 2023.” The oncology nutrition market is expected to reach USD 2.21 billion by 2023 from USD 1.46 billion in 2018, at a CAGR of 8.7%. The overall growth of the ... Read More
-
Global Helicobacter Pylori Diagnostics Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
... gastroduodenal diseases including chronic active gastritis, peptic ulcer diseases, atrophic gastritis, mucosa associated lymphoid tissue (MALT) lymphoma and noncardia gastric cancer. Scope of the Report: This report focuses on the Helicobacter Pylori Diagnostics in global ... Read More
-
Global Inflammatory Bowel Disease (IBD) Treatment Market Research Report 2018
... the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). The report firstly introduced the ... Read More
-
Ulcerative Colitis - Pipeline Review, H1 2018
... landscape. Ulcerative Colitis (Colitis ulcerosa or UC) is a chronic disease mainly of the large intestine or colon and a type of Inflammatory Bowel Disease (IBD). The disease is characterized by open sores and ulcers ... Read More
-
Antacids Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024
... the global antacids market to grow with a CAGR of 4% over the forecast period of 2018-2024. The study on antacids market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific ... Read More
-
EMEA (Europe, Middle East and Africa) Helicobacter Pylori Testing Market 2017 Forecast to 2022
... bacteria and to evaluate the effectiveness of treatment. Scope of the Report: This report focuses on the Helicobacter Pylori Testing in EMEA market, covering Europe, Middle East and Africa, This report categorizes the market based ... Read More
-
Gastroenteritis - Pipeline Review, H1 2018
... an infection of the gut. Symptoms include stomach pain, cramping, fever, nausea, and a headache. Causes of gastroenteritis include contaminated food or water, and contact with someone who has the virus. Treatment includes antibiotics, anti-emetic ... Read More
-
Global Colorectal Cancer Diagnostics and Therapeutics Market - Segmented by Diagnostics, Therapeutics, and Geography - Growth, Trends, and Forecast (2018 - 2023)
... a CAGR of 4.4% during the forecast period (2018-2023). The North American region holds the highest market share in colorectal cancer therapeutics and has been the dominant region globally for the colorectal cancer diagnostics and ... Read More
-
Global Gastrointestinal Partnering 2012-2018: Deal trends, players and financials
... in Gastrointestinal partnering deals Financial deal terms for headline, upfront and royalty by stage of development Gastrointestinal partnering agreement structure Gastrointestinal partnering contract documents Top Gastrointestinal deals by value Most active Gastrointestinal dealmakers Most of ... Read More
-
Global Inflammatory Bowel Disease Partnering 2012 to 2018
... leading healthcare companies. • Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering ... Read More
-
Global Peptic Ulcer Partnering 2012-2018
... Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered ... Read More
-
Global Irritable Bowel Syndrome Partnering 2012-2018
... companies. • Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and ... Read More
-
Global Ulcerative Colitis Partnering 2012-2018
... Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered ... Read More
-
Global Gastrointestinal Symptoms Partnering 2012 to 2018
... companies. • Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and ... Read More
-
HAE Therapeutics in Asia-Pacific Markets to 2023 - Growth Driven by Ongoing Shift towards Plasma-Derivative Products and Expected Launch of Premium Therapies
... of angioedema, without urticaria or pruritus, which most often affect the skin or mucosal tissues of the upper respiratory and gastrointestinal tracts. Although the swelling is self-limited, laryngeal involvement may cause fatal asphyxiation. HAE is ... Read More
-
Global Oncology Drugs Market 2018-2024
... in combination to control or destroy neoplastic cells. These agents can be either systemic or targeted. In systemic, the drug spreads throughout the body, whereas in targeted, the drug or substance identifies the specific location ... Read More
-
Oral Proteins and Peptides Market (3rd Edition), 2018-2030
... 1982. Earlier, most biologic drugs were delivered through the subcutaneous route. However, over time, advances in delivery formulations have enabled the development of orally administrable versions of therapeutic proteins / peptides. Owing to numerous compelling ... Read More
